[SCHEDULE 13G/A] BAXTER INTERNATIONAL INC Amended Passive Investment Disclosure
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 11 to a Schedule 13G/A reporting that it beneficially owns 0 shares of Baxter International Inc. common stock, representing 0% of the class after an internal realignment. The filing states certain Vanguard subsidiaries will report ownership separately in accordance with SEC Release No. 34-39538, effective with the reorganization described, and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries. The amendment is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Amendment reflects administrative disaggregation, not an economic sale.
The filing documents an internal reorganization within The Vanguard Group that causes certain subsidiaries to report beneficial ownership separately under SEC Release No. 34-39538. The Vanguard Group reports 0 shares and 0% ownership in Baxter following that realignment.
Cash‑flow treatment and any trading activity by the separated subsidiaries are not described in the excerpt; subsequent filings by the individual subsidiaries would show their reported positions if any.
FAQ
What did The Vanguard Group report for BAX in Amendment No. 11?
Why does Vanguard report zero ownership of Baxter (BAX)?
Does this filing show any purchases or sales of BAX by Vanguard?
When did Vanguard sign the Schedule 13G/A amendment for Baxter?
Will other Vanguard entities report Baxter holdings separately now?